2022 年 11 月 7 日

Calyx 先进的 IRT 自动化,为申办方节省时间和金钱

Intelligent functionality removes supply team burdens while ensuring drug availability and reducing waste

Nottingham, England and Morrisville, NC – 2022 年 11 月 7 日 Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, today announced an enhancement to its interactive response technology (IRT) system. By removing the supply monitoring burden from clinical trial teams, Calyx IRT’s automated supply strategy management reduces the cost of drug waste while ensuring study drug is available at investigative sites on time, every time.

Traditional IRT solutions require trial teams to constantly monitor patient recruitment levels and the unpredictable supply needs that arise during clinical trials, including randomization and damaged stock replacement. When trial teams don’t take the burdensome, manual steps to address changing site needs, high-enrolling sites risk stock-outs and failed patient visits, and low-enrolling sites end up with more supplies than needed, resulting in unnecessary drug waste.

“The act of consistently balancing appropriate site-level inventory without incurring excessive drug waste is difficult and time-consuming for most trial supply teams,” said Juan Munoz Pujol, Vice President of IRT at Calyx. “In addition to having confidence that Calyx IRT will get the right drug to the right patient at the right time, trial supply teams can now leverage automated supply strategy management to remove the burden of monitoring site stock against a site’s IRT settings and keep drug waste at a minimum. We are already seeing significant savings on clinical development budgets, especially in oncology trials and in other therapeutic areas where the expense of drug production is very high.”

Calyx’s automated supply strategy management is beneficial in numerous trial design scenarios and is particularly useful at reducing the burden on the clinical supply manager when a trial requires a large number of sites in order to meet patient enrolment goals.

Click here for more information on how Calyx IRT automated supply strategy management and other advanced functionalities drive clinical trial success.

关于凯理斯

凯理斯是一家全球顶尖的医学影像及临床信息化管理供应商,提供包括独立中心影像评估(IRC)、随机化和药品供应管理系统及服务(IRT)、临床试验管理系统(CTMS) 、临床试验电子数据采集系统(EDC)、eCTD递交及临床法规信息系统(RIM)等全面解决方案。 凯理斯服务申办方和临床研究组织 (CRO)已经近三十年,支持多达 60,000 项试验,成功帮助申办方通过了 650 个新药审批,惠及1,800 万名患者。经过近10年在中国新药研发行业的深耕,凯理斯中国团队已逾百人;通过全面深入的本土化,目前已服务近120家本土企业,同时和国内近10家顶尖药企及创新药公司达成企业级长期战略合作。

医学影像 | IRT | CTMS | EDC | RIM

Take your trials further with intelligent insights at Calyx.ai or at LinkedIn, Twitter, or Facebook.

联系人:

Christine Tobin | christine.tobin@calyx.ai | +1 412-628-8598


获取最新消息

不错过任何精彩内容。立即注册,接收涵盖行业新闻和其他相关信息的电子邮件,帮助您推进临床开发。

  • 此字段用于验证目的,应保持不变。
Powered by Translations.com GlobalLink OneLink Software